Mindray Medical International Limited Sustainability Profile
Mindray Medical International Limited, commonly known as Mindray, is a leading global provider of medical devices and solutions, headquartered in Shenzhen, China. Founded in 1991, the company has established a strong presence in over 190 countries, focusing on key operational regions such as North America, Europe, and Asia. Specialising in the development of innovative medical technologies, Mindray's core business areas include patient monitoring and life support, in-vitro diagnostics, and medical imaging. The company is renowned for its high-quality products, such as advanced ultrasound systems and versatile anaesthesia machines, which are distinguished by their reliability and user-friendly design. With a commitment to enhancing healthcare delivery, Mindray has achieved significant milestones, including numerous industry awards and recognitions. As a prominent player in the medical device industry, Mindray continues to drive advancements that improve patient outcomes and streamline clinical workflows.
DitchCarbon Score
How does Mindray Medical International Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mindray Medical International Limited's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mindray Medical International Limited's reported carbon emissions
Mindray Medical International Limited, headquartered in China (CN), has reported a significant reduction in carbon emission intensity for the year 2023, achieving an 8.51% decrease compared to 2022. This reduction pertains specifically to Scope 2 emissions, which are associated with the energy purchased and consumed by the company. While no absolute emissions data is currently available, the commitment to reducing carbon intensity reflects Mindray's proactive approach to climate action. The company has not set specific Science-Based Targets (SBTi) but continues to focus on improving its operational efficiency and sustainability practices. As part of its climate initiatives, Mindray is dedicated to enhancing its environmental performance, although further details on long-term targets or absolute emissions figures are not provided at this time. The absence of cascaded emissions data indicates that Mindray operates independently in its reporting and climate commitments.
How Carbon Intensive is Mindray Medical International Limited's Industry?
How Carbon Intensive is Mindray Medical International Limited's Location?
Mindray Medical International Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Mindray Medical International Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
